Lung cancer patients live longer with immune therapy
Monday, 16 April 2018 () For the first time, a treatment that boosts the immune system greatly improved survival in people newly diagnosed with the most common form of lung cancer. It's the biggest win so far for immunotherapy, which has had much of its success until now in less common cancers.
According to a new report, lung cancer patients live longer while on immune therapy. Using a combination of immunotherapy drugs, doctors found that pre-treating lung cancer patients before surgery can help eat away at tumors, while helping patients recover from the affects of chemotherapy. A lung...
The idea of turning the immune system against cancer got a big boost over the last few days, with a trio of studies showing the approach’s effectiveness... USATODAY.com - Front PageAlso reported by •SeattlePI.com •Seattle Times •Science Daily
Doctors have a powerful new approach to fighting lung cancer, the leading cause of cancer deaths. Two studies released Monday show drugs that boosted patients' immune systems can dramatically improve.. Source: CBS News -
Apr.16 -- Merck & Co. is cementing its lead in lung cancer therapy, fending off rival Bristol-Myers Squibb Co. after new data that could reshape treatment of the deadly disease. Bloomberg's Taylor.. Source: Bloomberg Global Business -
According to Business Insider, "New cancer treatments that harness the body's immune system are ready to go mainstream... cancer drugmakers showed that the use of immunotherapy in combination with.. Source: Wochit News -
There are plenty of great scenically-driven developments that could help people with cancer treat it more effectively. New trials are being created constantly that alter cells, and try to galvanize.. Source: NowThis News -